You are here
May 2014 We report on a pioneer program in México City designed to educate expectant mothers about both cord blood donation and private storage, made possible by the cooperation, to mutual benefit, of public and private institutions. Cordón Vital, a private (family) cord blood bank active in México City since 2001, together with Médica Sur Lomas Woman's Hospital, a private obstetric hospital (formerly Hospital Santa Teresa), formed an alliance in April 2007 with the public cord blood bank of the México Social Security Institute (IMSS) that was founded in 2005.
May 2014 Omega-3 fatty acids are called "essential" because they are required for a healthy metabolism. Humans and other mammals must ingest the simplest essential fatty acids in their diet, because their bodies cannot synthesize them. The best dietary source is fish oil. Docosahexaenoic acid (DHA) is a more complex fatty acid that our bodies can manufacture to a limited extent.
May 2014 Mesenchymal stem/stromal cells (MSC) are being widely studied in research and in clinical trials. Their useful properties include the ability to modulate the patient's immune system, promote cell growth, and to differentiate into more specialized cell types. This amazing potential has been explored in a large scope of diagnoses such as graft versus host disease (GvHD), rheumatoid arthritis, cardiomyopathy, liver cirrhosis, Alzheimer's, spinal cord injury, chronic wounds, and diabetes among many others [1,2].
Apr 2014 During the last 25 years, stem cells derived from umbilical cord blood have been used in more than 30,000 transplants performed worldwide for the treatment of over 80 diseases and disorders in both adults and children. The evolution of stem cell therapies has paved the way for further research being conducted through FDA-regulated clinical trials to uncover their potential in regenerative medicine applications.
Apr 2014 The Hearing Loss Association of America® (HLAA) is the nation's foremost membership and advocacy organization for people with hearing loss. The mission of HLAA is to open the world of communication for people with hearing loss through information, education, support and advocacy.
Apr 2014 This simple question has been lingering unanswered over private cord blood banks around the world for years. Despite compelling data on the growing therapeutic use of cord blood, both in terms of treatable diseases and numbers of therapies, often medical doctors are still reluctant to embrace the value of family cord blood banking. In many countries, such as Brazil, this sector is still plagued with mostly unfounded controversy, such as the "public versus private" banking debate.
Mar 2014 Babies born prematurely often have serious medical complications that impact their lungs, brain, kidneys and intestinal systems. Stem cells in the umbilical cord blood and tissue, collected after the baby is born, may offer new treatment options for these premature babies. In an effort to understand the potential for the babies' newborn stem cells to be used in such treatments, ViaCord established a pilot program in partnership with Miracle Babies charity and Sharp Mary Birch Hospital in San Diego.
Mar 2014 Borne's goal is to make childbirth safer and promote lifelong health for mothers and babies. Borne was set up in response to a need for greater research into the risks of premature birth. In the UK, more than 1 in 10 babies are born too soon. Worldwide, 15 million babies are born prematurely every year, and this is responsible for 70% of disability and death in newborn babies.
Mar 2014 Each year in the US, nearly 500,000 babies are born premature. That's 1 of every 8 infants born in the United States. A premature birth is when a baby is born before 37 completed weeks of pregnancy. A full-term pregnancy is 40 weeks. In almost all countries with reliable data, preterm birth rates are increasing.
Feb 2014 There is growing acceptance in the medical community that stem cells derived from cord blood have value as a therapy for pediatric neurologic injury. But what financial hurdles do parents face when they attempt to access that value for their children? In this article we present a case study of the out-of-pocket costs that parents face when they use their child's own (autologous) cord blood as therapy for cerebral palsy, and receive the treatment at Duke University Medical Center ("Duke" hereafter).